Stockscreener 앱 받기
5.41
20.91%
-1.43
시장 영업 전:
5.53
0.12
+2.22%
Harvard Bioscience Inc 주식(HBIO)의 최신 뉴스
Harvard Bioscience Q1 2026 Earnings Call Transcript - MarketBeat
Harvard Bioscience (HBIO) Reports Q1 Earnings and Reaffirms 2026 Revenue Guidance - GuruFocus
Discontinued operations of Harvard Bioscience, Inc. – FWB:HBI0 - TradingView
Harvard Bioscience Reaffirms Full-Year 2026 Financial Guidance >HBIO - Moomoo
Harvard Bioscience Inc (HBIO) Q1 2026 Earnings Call Highlights: Revenue Growth Driven by New Product Innovations - GuruFocus
[10-Q] HARVARD BIOSCIENCE INC Quarterly Earnings Report - Stock Titan
Harvard Bioscience, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
HBIO Forecasts Q2 Margins and Revenue Growth - GuruFocus
HBIO Sees Q1 Revenue at $20.8M, Positive Trends in Product Adoption - GuruFocus
Earnings call transcript: Harvard Bioscience Q1 2026 misses EPS forecast, stock drops - Investing.com UK
HBIO Maintains Positive Outlook for FY26 Financial Performance - GuruFocus
Harvard Bioscience reaffirms 2026 outlook for 2%-4% revenue growth as Project Viking targets $4M annual savings - MSN
Harvard Bioscience Still Sees 2026 Revenue Up 2%-4% >HBIO - Moomoo
Harvard Bioscience Q1 2026 slides: margins rise amid revenue miss By Investing.com - Investing.com Australia
Harvard Bioscience (HBIO) Q1: EPS Not Disclosed, Revenue $20.8M - GuruFocus
Harvard Bioscience Announces Q1 2026 Financial Results: $20.8M Revenue, 59% Gross Margin, Key SEC Filing Details 9 - Minichart
Harvard Bioscience Accelerates Growth with Human-Relevant Translational Tools, Leading Recurring Revenue and Innovation in Preclinical Research (May 2026) 10121415 - Minichart
Harvard Bioscience Still Sees 2026 Adjusted Ebitda Up 6%-10% >HBIO - Moomoo
Harvard Bioscience Inc (NASDAQ:HBIO) Q1 Results Show Revenue Miss Offsets Earnings Beat - ChartMill
HARVARD BIOSCIENCE ($HBIO) Releases Q1 2026 Earnings - Quiver Quantitative
Harvard Bioscience Announces First Quarter 2026 Financial Results - The Manila Times
Harvard Bioscience: Q1 Earnings Snapshot - marketscreener.com
Harvard Bioscience (NASDAQ: HBIO) details debt refinancing, FY26 outlook and $7M convertible loan - Stock Titan
Harvard Bioscience (NASDAQ: HBIO) Q1 2026 margin up as loss shrinks - Stock Titan
Harvard Bioscience narrows quarterly loss as margins rise - Stock Titan
Inventory turnover of Harvard Bioscience, Inc. – LS:A423J5 - TradingView
MSN Money - MSN
Harvard Bioscience Inc expected to post a loss of 62 cents a shareEarnings Preview - TradingView
Harvard Bioscience to Participate in Upcoming Investor Conferences - 富途牛牛
HBIO News | HARVARD BIOSCIENCE INC (NASDAQ:HBIO) - ChartMill
When Should You Buy Harvard Bioscience, Inc. (NASDAQ:HBIO)? - simplywall.st
Earnings Preview: HBIO to Report Financial Results Pre-market on May 12 - Moomoo
Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET - marketscreener.com
HBIO Harvard Bioscience Inc. posts 100 percent Q4 2025 EPS miss vs estimates, shares rise 3.72 percent in today's trading.Most Discussed Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
Harvard Bioscience (HBIO) Quarterly Preview | Q4 2025: Below ExpectationsOpen Stock Signal Network - Cổng thông tin điện tử tỉnh Lào Cai
Harvard Bioscience (HBIO) 2026 proxy details director elections and equity plans - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm
HBIO Stock Price, Quote & Chart | HARVARD BIOSCIENCE INC (NASDAQ:HBIO) - ChartMill
Harvard Bioscience (HBIO) price target increased by 200.00% to 6.12 - MSN
Will Harvard Bioscience Inc outperform tech stocks2026 Key Lessons & Community Verified Swing Trade Signals - baoquankhu1.vn
Options Flow: Whats the fair value of Harvard Bioscience Inc stockPortfolio Risk Summary & Capital Efficient Trade Techniques - baoquankhu1.vn
Profit Recap: What are analysts price targets for Harvard Bioscience IncPrice Action & Low Volatility Stock Suggestions - baoquankhu1.vn
HBIO | Harvard Bioscience Inc Insider Trading - Quiver Quantitative
2.05%
3.17%
자본화:
|
볼륨(24시간):